Study on biomarkers related to hypertension in Guangdong Province

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between biomarkers and adverse health outcomes in individuals diagnosed with hypertension. Participants aged 18 and older will provide whole blood samples and undergo physical examinations and surveys at baseline. The study will track the incidence of all-cause and cardiovascular mortality during follow-up to better understand the impact of these biomarkers. The research focuses on a diverse population within Guangdong Province, emphasizing the public health implications of hypertension.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥18 years old
* In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)

Exclusion Criteria:

* \<18 years old
* Unsigned informed consent
* Pregnant Women and Lactation

Where it's running

• Guangdong Provincial People's Hospital
  Guangzhou, Guangdong, China Recruiting
• Guangdong Cardiovascular Institute
  Guangzhou, Guangdong, China Recruiting

Study contacts

• Study coordinator: Feng Ying-qing, PhD
• Email: 651792209@qq.com
• Phone: 86-2083827812

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China

  A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.

  Recruiting at 2 sites Jiangsu Province (Suqian) Hospital · Suqian, Jiangsu and 1 other locations · NCT07628283

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• RADIANCE CED: long-term outcomes after ultrasound renal denervation

  This project will see if ultrasound renal denervation (using the Paradise system) lowers blood pressure over the long term in Medicare-age adults (65+) with uncontrolled hypertension by using their medical records.

  Recruiting at 2 sites ReCor Medical, Inc. · Detroit, Michigan and 1 other locations · NCT07231757

• Pulmonary Artery Denervation for a specific type of heart and lung pressure problem

  This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.

  Recruiting at 18 sites Pulnovo Medical, Inc. · Tucson, Arizona and 18 other locations · NCT07214376

• Postpartum program to prevent cardiometabolic problems after preeclampsia

  This study will test a 9-month app-based support program to lower blood pressure and help with weight loss in first-time mothers who recently had preeclampsia.

  Recruiting at 2 sites Karolinska Institutet · Stockholm, Stockholm County and 1 other locations · NCT07199283

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.